13 Tue
All-day
12:00 am
1:00 am
2:00 am
3:00 am
4:00 am
5:00 am
6:00 am
7:00 am
8:00 am
9:00 am
10:00 am
11:00 am
12:00 pm
1:00 pm
2:00 pm
3:00 pm
4:00 pm
5:00 pm
6:00 pm
7:00 pm
8:00 pm
9:00 pm
10:00 pm
11:00 pm
11:50 am Invited Talk: Pertubation of DNA topology in mycobacteria @ Acharya Hall
Invited Talk: Pertubation of DNA topology in mycobacteria @ Acharya Hall
Aug 13 @ 11:50 am – 12:12 pm
Invited Talk: Pertubation of DNA topology in mycobacteria @ Acharya Hall | Vallikavu | Kerala | India
V. Nagaraja Ph.D. Professor, Indian Institute of Science, Bengaluru, India Perturbation of DNA topology in mycobacteria To maintain the topological homeostasis of the genome in the cell, DNA topoisomerases catalyse DNA cleavage, strand passage and rejoining of the ends. Thus,
1:40 pm Plenary Talk: Biomaterials: Future Perspectives @ Amriteshwari Hall
Plenary Talk: Biomaterials: Future Perspectives @ Amriteshwari Hall
Aug 13 @ 1:40 pm – 2:16 pm
Plenary Talk:  Biomaterials: Future Perspectives @ Amriteshwari Hall | Vallikavu | Kerala | India
Seeram Ramakrishna, Ph.D. Director, Center for Nanofibers & Nanotechnology, National University of Singapore Biomaterials: Future Perspectives From the perspective of thousands of years of history, the role of biomaterials in healthcare and wellbeing of humans is at best accidental. However,
3:55 pm Delegate Talk: Pharmacophore modeling, atom-based 3D-QSAR and molecular docking studies on Pyrimido[5,4-e][1,2,4]triazine derivatives as PLK 1 inhibitors @ Sathyam Hall
Delegate Talk: Pharmacophore modeling, atom-based 3D-QSAR and molecular docking studies on Pyrimido[5,4-e][1,2,4]triazine derivatives as PLK 1 inhibitors @ Sathyam Hall
Aug 13 @ 3:55 pm – 4:10 pm
Delegate Talk: Pharmacophore modeling, atom-based 3D-QSAR and molecular docking studies on Pyrimido[5,4-e][1,2,4]triazine derivatives as PLK 1 inhibitors @ Sathyam Hall | Vallikavu | Kerala | India
Rajasekhar Chekkara, Venkata Reddy Gorla and Sobha Rani Tenkayala Pharmacophore modeling, atom-based 3D-QSAR and molecular docking studies on Pyrimido[5,4-e][1,2,4]triazine derivatives as PLK 1 inhibitors Polo-like kinase 1 (PLK1) is a significant enzyme with diverse biological actions in cell cycle progression,